Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > EU : list of medicinal products under additional monitoring
EU_list-medicinal-products-under-additional-monitoring_en-0_22Jul2022-1Télécharger
Marie Berger 29 July 2022 All news
  • ← Oral methotrexate medicines (Imeth, Novatrex and generics): a patient card and a health professional brochure to avoid overdose
  • The risk of myocarditis is increased but remains low after the first booster dose with an mRNA vaccine, and this risk decreases with increasing time between doses →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022
  • Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
  • MedDRA : whatsnew ?
Copyright © 2018 - Pharmya - Legal terms - Quality Policy